HCW Biologics is trading at $3.96 (23.8% up) today after an SEC filing revealed that CEO and 10% owner Hing Wong purchased 23,210 shares at $2.59 on July 29, 2026.
- The transaction adds to a total of 137,089 shares accumulated by the CEO over the past 12 months.
- The insider activity signals significant confidence in the company’s proprietary TOBI platform and is the primary catalyst behind today's sharp move higher.